Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker R Jacobs

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Onkologie|September 9, 2009
Cost analysis comparing an anthracycline/docetaxel regimen to CMF in patients with early stage breast cancerMichael Braun, Volker R Jacobs, Stefan Wagenpfeil, et al.
Experimental Cell Research|July 6, 2010
Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sourcesNikolas Kaltz, Jochen Ringe, Christina Holzwarth, et al.
Academic Radiology|April 16, 2005
Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXXHeike E Daldrup-Link, Martina Rudelius, Robert A J Oostendorp, et al.
Journal of Minimally Invasive Gynecology|October 11, 2005
Development of a thinner and more flexible type of minihysteroscope with a controlled 90-degree bendable tip for vision-guided endometrium biopsyVolker R Jacobs, Stefan Paepke, Ulrike Schwarz-Boeger, et al.
Onkologie|May 9, 2006
Critical appraisal of primary systemic endocrine therapy in receptor-positive postmenopausal breast cancer: an updateStefan Paepke, Volker R Jacobs, Daniela Paepke, et al.
Onkologie|February 12, 2009
Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AMLAnne K Baumgärtner, R Oberhoffer, Volker R Jacobs, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2016
Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experienceIris Mueller, Gerhard Kametriser, Volker R Jacobs, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancerSophie Marguet, Chafika Mazouni, Bram L T Ramaekers, et al.
Breast Cancer Research and Treatment|April 10, 2013
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancerVolker R Jacobs, Ronald E Kates, Eva Kantelhardt, et al.
Onkologie|May 18, 2011
Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancerAngela Ihbe-Heffinger, Bernadette J Paessens, Christoph von Schilling, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Onkologie|September 9, 2009
Cost analysis comparing an anthracycline/docetaxel regimen to CMF in patients with early stage breast cancerMichael Braun, Volker R Jacobs, Stefan Wagenpfeil, et al.
Experimental Cell Research|July 6, 2010
Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sourcesNikolas Kaltz, Jochen Ringe, Christina Holzwarth, et al.
Academic Radiology|April 16, 2005
Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXXHeike E Daldrup-Link, Martina Rudelius, Robert A J Oostendorp, et al.
Journal of Minimally Invasive Gynecology|October 11, 2005
Development of a thinner and more flexible type of minihysteroscope with a controlled 90-degree bendable tip for vision-guided endometrium biopsyVolker R Jacobs, Stefan Paepke, Ulrike Schwarz-Boeger, et al.
Onkologie|May 9, 2006
Critical appraisal of primary systemic endocrine therapy in receptor-positive postmenopausal breast cancer: an updateStefan Paepke, Volker R Jacobs, Daniela Paepke, et al.
Onkologie|February 12, 2009
Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AMLAnne K Baumgärtner, R Oberhoffer, Volker R Jacobs, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 29, 2016
Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experienceIris Mueller, Gerhard Kametriser, Volker R Jacobs, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2016
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancerSophie Marguet, Chafika Mazouni, Bram L T Ramaekers, et al.
Breast Cancer Research and Treatment|April 10, 2013
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancerVolker R Jacobs, Ronald E Kates, Eva Kantelhardt, et al.
Onkologie|May 18, 2011
Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancerAngela Ihbe-Heffinger, Bernadette J Paessens, Christoph von Schilling, et al.
Pageof 7